Nichi-Iko Pharmaceutical Co Stock

Nichi-Iko Pharmaceutical Co Employees 2025

Nichi-Iko Pharmaceutical Co Employees

1,954

Ticker

4541.T

ISIN

JP3687200000

WKN

A0DQVE

In 2025, Nichi-Iko Pharmaceutical Co employed 1,954 people, a 0% change from the 0 number of employees in the previous year.

Nichi-Iko Pharmaceutical Co Aktienanalyse

What does Nichi-Iko Pharmaceutical Co do?

Nichi-Iko Pharmaceutical Co Ltd is a Japanese company founded in 1965 by Shin-ichi Oka. The company is now one of the largest generic drug manufacturers in Japan and has also made a name for itself in the international market in recent years. Nichi-Iko currently employs about 4800 people and is headquartered in Toyama, Japan. The business model of Nichi-Iko is focused on producing high-quality and cost-effective generic drugs for the global market. The company has an extensive research and development department that continuously develops and improves new products. The goal is to offer a wide range of medicines to meet the needs of patients in different countries. Nichi-Iko has various divisions that the company focuses on. One of the most important divisions is oncology products. Nichi-Iko has a wide range of products for cancer treatment on the market. The company has also expanded into other areas such as infectious diseases, cardiology, neurology, and dermatology. The product range includes tablets, capsules, injection solutions, eye drops, and inhalation products. The company also has an extensive distribution infrastructure that focuses on strengthening its global presence. Nichi-Iko has branches in Japan, the United States, Europe, and Asia. The presence in the global market has helped the company distribute its products in more than 50 countries. Nichi-Iko places a high value on quality control. The company has quality control facilities such as the central laboratory and research and development department. The company takes responsibility for the quality of its products and enables doctors and pharmacists to prescribe safe and effective medicines to their patients. Nichi-Iko also strives for a more sustainable future. The company is committed to promoting environmentally friendly business practices. Nichi-Iko is committed to reducing its energy and water consumption, as well as reducing its waste products. The company has also launched an initiative to promote medication recycling in order to expand the possibilities of using medical waste. In summary, Nichi-Iko Pharmaceutical Co Ltd is a leading generic drug manufacturer focused on producing high-quality and cost-effective medicines. The company has expanded into various areas and operates in the global market. Nichi-Iko places great importance on quality control and is committed to being more environmentally friendly. Nichi-Iko Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Nichi-Iko Pharmaceutical Co's Employee Base

Nichi-Iko Pharmaceutical Co's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Nichi-Iko Pharmaceutical Co's operational capacity and future potential.

Year-to-Year Comparison

Assessing Nichi-Iko Pharmaceutical Co's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Nichi-Iko Pharmaceutical Co's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Nichi-Iko Pharmaceutical Co’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Nichi-Iko Pharmaceutical Co stock

How many employees does Nichi-Iko Pharmaceutical Co have this year?

Nichi-Iko Pharmaceutical Co has 1,954 undefined employees this year.

How many employees did Nichi-Iko Pharmaceutical Co have compared to the previous year?

Compared to the previous year, Nichi-Iko Pharmaceutical Co had 0% more employees.

What impact did the number of employees have on the company Nichi-Iko Pharmaceutical Co?

The number of employees has a direct impact on the efficiency and productivity of Nichi-Iko Pharmaceutical Co. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Nichi-Iko Pharmaceutical Co?

The number of employees can also have an impact on investors of Nichi-Iko Pharmaceutical Co, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Nichi-Iko Pharmaceutical Co affect the company?

An increase in equity of Nichi-Iko Pharmaceutical Co can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Nichi-Iko Pharmaceutical Co's equity affect the company?

A reduction in equity of Nichi-Iko Pharmaceutical Co can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Nichi-Iko Pharmaceutical Co?

Some factors that can influence the equity of Nichi-Iko Pharmaceutical Co include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Nichi-Iko Pharmaceutical Co so important for investors?

The equity of Nichi-Iko Pharmaceutical Co is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Nichi-Iko Pharmaceutical Co influence the company?

The number of employees at Nichi-Iko Pharmaceutical Co can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Nichi-Iko Pharmaceutical Co evolved in recent years?

In recent years, the number of employees at Nichi-Iko Pharmaceutical Co has changed by NaN.

How many employees does Nichi-Iko Pharmaceutical Co currently have?

Nichi-Iko Pharmaceutical Co currently has 1,954 undefined employees.

Why is the number of employees important for investors of Nichi-Iko Pharmaceutical Co?

The number of employees is important for investors of Nichi-Iko Pharmaceutical Co as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Nichi-Iko Pharmaceutical Co take to change the number of employees?

To change the number of employees, Nichi-Iko Pharmaceutical Co can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Nichi-Iko Pharmaceutical Co pay?

Over the past 12 months, Nichi-Iko Pharmaceutical Co paid a dividend of 20 JPY . This corresponds to a dividend yield of about 57.14 %. For the coming 12 months, Nichi-Iko Pharmaceutical Co is expected to pay a dividend of -42.49 JPY.

What is the dividend yield of Nichi-Iko Pharmaceutical Co?

The current dividend yield of Nichi-Iko Pharmaceutical Co is 57.14 %.

When does Nichi-Iko Pharmaceutical Co pay dividends?

Nichi-Iko Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of April, October, April, October.

How secure is the dividend of Nichi-Iko Pharmaceutical Co?

Nichi-Iko Pharmaceutical Co paid dividends every year for the past 0 years.

What is the dividend of Nichi-Iko Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to -42.49 JPY are expected. This corresponds to a dividend yield of -121.39 %.

In which sector is Nichi-Iko Pharmaceutical Co located?

Nichi-Iko Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Nichi-Iko Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Nichi-Iko Pharmaceutical Co from 12/1/2021 amounting to 10 JPY, you needed to have the stock in your portfolio before the ex-date on 9/29/2021.

When did Nichi-Iko Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 12/1/2021.

What was the dividend of Nichi-Iko Pharmaceutical Co in the year 2024?

In the year 2024, Nichi-Iko Pharmaceutical Co distributed 0 JPY as dividends.

In which currency does Nichi-Iko Pharmaceutical Co pay out the dividend?

The dividends of Nichi-Iko Pharmaceutical Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Nichi-Iko Pharmaceutical Co

Our stock analysis for Nichi-Iko Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nichi-Iko Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.